Fully agree that there is nothing new
Less emphasis on jacobs hope program
Cantrixil, Anisina, aiming for human trials at some point in 2016
Trilexium (TRXE-009) human trials by 2017
IMO, the excitement and constant flow of news around the CR led many to believe that human trials were much closer than the company has anticipated
DYOR
New CEO hopefully appointed by years end